Radiologic maxillary sinusitis is an important risk factor for development of bronchopneumonia in mechanically ventilated patients. Nitric oxide produced within the paranasal sinuses is considered to provide an anti-bacterial environment and to modulate mucociliary clearance function. We hypothesized that a reduced formation of nitric oxide might contribute to the compromised local host defense in radiologic maxillary sinusitis and measured nitric oxide levels directly within maxillary sinuses of septic patients with radiologic maxillary sinusitis (n=11), whose sinuses were fenestrated to eliminate a possible septic focus. Data were compared with those in patients without airway inflammation (n=11, controls). Despite of local inflammation and infection, we found considerably lower maxillary nitric oxide levels than in controls (31±10 vs. 2554±385 parts per billion, mean ± standard error of the mean, P<0.001). Consistently, immunohistochemical and in situ hybridization investigations revealed strongly reduced expression of inducible nitric oxide synthase. Applying ultrastructural immunolocalization, we identified cilia and microvilli of the maxillary sinus epithelium as the major nitric oxide production site in controls. Our findings provide evidence for a markedly reduced nitric oxide production in maxillary sinuses of patients with radiologic maxillary sinusitis and sepsis that implicates impaired local host defense and an increased risk for secondary infections.
Introduction
Radiologic maxillary sinusitis (RMS), defined as presence of unilateral or bilateral opacification on a paranasal computerized tomography scan, reflecting air-fluid levels within the maxillary sinuses, is a frequent complication in critically ill patients (1). If contaminated with hospital acquired pathogens, the stagnant secretions may cause the development of a nosocomial infectious sinusitis which is considered as a possible focus of sepsis and as an important risk factor for ventilator-associated pneumonia (2). Nosocomial pneumonia significantly increases length of stay and mortality in the intensive care unit (3). The underlying mechanisms for fluid retention and compromised immune defense in RMS are not known. There is, however, experimental evidence that nitric oxide (NO) influences primary host defense. Thus, it has been demonstrated that the NO synthase antagonist N G -monomethyl-L-arginine reduced ciliary beat frequency in prestimulated bovine bronchial epithelial cells by 40% (4). In similar fashion, N G -monomethyl-L-arginine blocked the increase in ciliary beat frequency evoked by the stimulation of muscarinic receptors in ciliated epithelial cells of human tonsils (5). Consequently, inhalation of the nebulized NO donor nitroprusside in human volunteers at a dose of 3 mg increased nasal mucociliary activity in vivo by 57% (6). Apart from its effects on ciliary function, NO is considered to take part in nonspecific immune defense mechanisms by its ability to inhibit the growth of microorganisms (7-9). Furthermore, it is an endogenous inhibitor of both basal and neurogenic mucus secretion in rodents (10).
Nitric oxide is produced endogenously within the respiratory tract and is detectable in exhaled gas of humans and other mammals (11, 12) . Following the discovery that more than 80% of the total exhaled quantity is released into the upper airways (13, 14) , the epithelial cells in the paranasal sinuses were identified as the major source of NO release into the respiratory tract (15) .
Nitric oxide concentrations of several thousand parts per billion (ppb) were measured directly within the maxillary sinuses of healthy adult volunteers. Molecular biochemical investigations suggested a constitutively expressed enzyme sharing messenger ribonucleic acid sequence homology with human hepatocyte inducible nitric oxide synthase (iNOS) to be almost exclusively responsible for paranasal NO production in healthy adults (15) .
We hypothesized that a reduced maxillary NO synthesis might contribute to the impaired local host defense in RMS. In this study, we investigated maxillary NO release and ultrastructural localization of iNOS in patients with RMS and sepsis. Data were compared with those from patients who underwent maxillofacial surgery to correct for dysgnathia. These patients were free of systemic and airway inflammation and served as controls.
Methods

Study population
The study protocol was approved by the local ethics committee. With written informed consent given by themselves or by the next of kin, 22 intubated and mechanically ventilated adult patients (11 male, 11 female, body weight 77±5 kg, age 39±3 years) were included in the study. Eleven were critically ill patients fulfilling criteria for RMS (1): total opacification or presence of an air fluid level within one or both maxillary sinuses in computerized tomography scans (for details concerning duration of mechanical ventilation, tubing routes, and positional maneuvers see online data supplement). All patients with RMS fulfilled the criteria of sepsis (n=1 sepsis; n=3 severe sepsis; n=7 septic shock) according to the current definition (16) and underwent
Microbiological, histological, immunohistochemical, and in situ hybridization investigations
Swabs for bacterial cultures and open mucosal biopsies of maxillary sinus epithelium were taken from n=6 patients and n=6 controls. Histopathological examinations were based on hematoxylineosin staining. Cryostat sections of 5 µm were treated with a primary anti-iNOS antibody (20) diluted 1:200. For signal detection, a secondary horse-radish peroxidase-conjugated swine antirabbit antibody (DAKO, Copenhagen, Denmark), diluted 1:100 was applied. Fine structural immunoperoxidase labeling was accomplished according to an established protocol (21) . Briefly, 30-µm-thick cryostat sections were incubated with the primary anti-iNOS antibody diluted 1:25 overnight, followed by treatment with the secondary peroxidase-labeled antibody, diluted 1:25.
Semithin (1 µm) and ultrathin (60 nm) sections were viewed by light or electron microscopy,
respectively. An iNOS riboprobe was generated from a 3130-3853 base pair complementory deoxyribonucleic acid. Hybridization on 5 µm cryostat sections was performed as described elsewhere (22) overnight at 50°C with 30 ng probe in 40 µl buffer. Sections were then incubated for 2 hours with an anti-digoxigenin antibody (DAKO) diluted 1:50, washed, and analyzed by high resolution interference-contrast microscopy (for details of the techniques and quantification of histologies and immunostaining see online data supplement).
Statistical analysis
Differences between groups were explored with the Mann-Whitney-U test. Intra-group comparisons were performed using the Friedman ANOVA followed by post hoc tests according to Wilcoxon with Bonferroni's correction. Correlation analysis was performed with the Spearman rank correlation coefficient (SPSS statistical software, version 10.0.7; SPSS, Chicago, IL). Statistical significance was accepted for P<0.05. Data are presented as mean ± standard error of the mean.
Results
In patients with RMS and sepsis (n=11), mean NO concentrations measured in the maxillary sinuses within 24 hours after fenestration were significantly and markedly lower than those in patients with healthy paranasal sinuses (n=11) ( 31 ± 10 ppb vs. 2554 ± 385 ppb, P<0.001; see Table 1 ). These values corresponded to net NO excretion rates of 2 ± 1 nl/minute, and 254 ± 39 nl/minute, respectively (P<0.001, patients with RMS and sepsis vs. controls). Nitric oxide levels within the maxillary sinuses exceeded those measured in ambient air in all cases (P<0.01 both for controls and patients with RMS and sepsis) demonstrating an endogenous NO production. In controls, maxillary nitrogen dioxide concentration was significantly increased compared with ambient air (P<0.01), but remained below 10% of the corresponding NO levels indicating no substantial NO/nitrogen dioxide conversion by reaction with oxygen. Data of NO measurements conducted on various subsequent days following fenestration in n=8 patients with RMS are displayed in Figure 1 . Within three days, NO concentration remained in the same range (day 1: 21 ± 9 ppb, days 2-3: 48 ± 17 ppb; n.s.). Additional determinations, conducted between days 4 and 27, revealed an increase in NO concentration to 554 ± 5 ppb (P<0.05 vs. day 1, and P<0.05 vs. days 2-3). Only in one patient, a "normal" value of 1780 ppb was detected. At the time of the measurement this patient still received corticosteroids (hydrocortisone 250 mg/ day i.v.).
We did not detect a relationship between either the number of sinus cavities affected, the presence of acute respiratory distress syndrome, or the use of corticosteroids, and the NO release into the maxillary sinuses in patients with RMS and sepsis. There was no correlation between the number of diseased sinuses and the maxillary NO concentration (r=-0.06; P=0.86; n.s.), or the net NO excretion rate (r=0.06; P=0.86; n.s.). Nitric oxide levels in the maxillary sinuses were comparable in patients with and without acute respiratory distress syndrome (32 ± 14 ppb, and 30 ± 14 ppb, respectively; P=0.86; n.s.). The range of values for the net NO excretion rate was not significantly different among RMS patients who received low-dose hydrocortisone (1-6 nl/minute) and RMS patients without administration of corticosteroids (1-9 nl/minute) (P=0.27; n.s.).
To study the pathophysiological mechanisms for the reduced NO production, we investigated the expression of iNOS protein and iNOS specific messenger ribonucleic acid in ciliated epithelial cells of the maxillary sinuses. Using immunohistochemical peroxidase-labeled staining of iNOS in controls and patients with RMS and sepsis (each n=6 biopsies) we found substantial differences between these groups. In all controls, reaction of iNOS immunoreactivity exhibited a distinct apical staining of the epithelial cells. In contrast, in patients with RMS and sepsis, iNOS immunoreactivity was faint or absent (Figure 2a, b) . A quantitative analysis of the immunostaining was performed in n=5 controls and in n=5 patients with RMS and sepsis. Total optical density as calculated by summing up optical densities over all pixel areas with signals due to immunostaining was significantly different between groups (controls: 22.9 ± 2.4; RMS group:
11.4 ± 1.6; P<0.01). Accordingly, there was a tenfold difference in total pixel areas with signal between controls and RMS patients (controls: 27000 ± 8100 pixel areas; RMS group: 2700 ± 300 pixel areas; P<0.01).
Detailed analysis of iNOS levels in our control patients showed that the immunoreactivity was located within the cilia. The signal was strongest in the apical zone of the epithelium directly beneath the luminal cell membrane, and in the basal part of cilia (Figure 3 
Discussion
To investigate whether RMS is associated with a locally decreased NO production, we measured NO levels directly within the sinus lumen and investigated iNOS expression in the maxillary sinus epithelium. We found that patients with RMS and sepsis, in contrast to controls without airway inflammation, had a significant and sustained decrease in NO release into the maxillary sinuses. Using immunohistochemical and in situ hybridization methods, we demonstrated that this was related to a markedly attenuated abundance of iNOS protein and iNOS messenger ribonucleic acid in the surface lining epithelium. Our results in controls confirm the previously reported finding of Lundberg et al. (15) that the abundance of iNOS in apical regions of the maxillary sinus epithelium is responsible for the high NO levels within the sinus lumen of healthy adult volunteers. Further, we provide the first evidence that maxillary iNOS in human subjects free of airway inflammation is mainly localized within cilia and microvilli. The different distribution of iNOS messenger ribonucleic acid over large parts of the epithelial cells reflects an effective targeting mechanism of the protein from its site of translation to its final destination site. The resulting spatially restricted localization of iNOS supports NO release into the sinus lumen and simultaneously reduces adverse effects on the cell nucleus. It is well known that microorganisms invading cilia may cause ultra-structural changes of the microtubuli leading to mucociliary dysfunction (23) . Work from several authors reveals that the NO concentrations we found in the maxillary sinuses of controls suffice to block the growth of cultured bacteria and viruses (7-9). This provides an efficient mechanism for nonspecific host defense.
In addition, the NO production within the cilia may favor modulation of ciliary beat frequency by direct action on dynein arms. Endogenous NO leads to formation of cyclic guanosine monophosphate which in turn activates protein kinase G. The latter, in the end, evokes the effects of the signal transduction pathway via phosphorylation (24) . Experimental studies indicate two molecularbiological mechanisms. First, proteinkinase G may induce a calcium influx (25) subsequently leading to an up-regulation of dynein adenosine triphosphatase (26) . Second, Gkinase phosphorylates a part of the dynein-associated proteins at the axons of the cilia (27, 28) . In cytoplasmatic dynein, such subunits influence the dynein-adenosine triphosphatase activity (29, 30) . Accordingly, previous studies showed a ciliary beat frequency of 17 Hertz in epithelial cells from human maxillary sinus (31) versus a ciliary beat frequency of 11 Hertz in human epithelial cells taken from the concha nasalis inferior (32) , where only weak iNOS activity has been reported (15) . We hypothesize that the high NO production within the paranasal sinuses contributes to maintain ciliary beat frequency on a level which is sufficient for an optimal mucociliary clearing function. Since the sinus ostia are not located at the anatomically lowest level, a continuous, highly efficient active transport is required to avoid mucus plugging within the maxillary sinuses.
In general, pro-inflammatory cytokines and lipopolysaccharides have the potential to induce iNOS expression. Consequently, several inflammatory diseases, which affect the interstitium and airway epithelium are associated with an increased NO release into the airways. This explains increased levels of exhaled NO in asthmatics (33) , in patients with fibrosing alveolitis (34), bronchiectasis (35) , lymphocytic bronchiolitis (36) , and allergic rhinitis (37) . Various studies provided indirect evidence for an increased iNOS expression as primary reason for the impaired vascular reactivity in the acute phase of sepsis. Accordingly, patients with sepsis have increased nitrite and nitrate plasma levels which cannot be explained by renal dysfunction alone (38) . In experimental models of the disease, iNOS deficient mice were found to be superior compared with wild types in terms of survival rate and maintenance of systemic blood pressure (39) . With regard to these findings, our results appear to be paradox: maxillary sinus iNOS expression and NO release are considerably high in controls without infection while they are almost completely absent in patients with RMS and sepsis. This is, to our knowledge, the first in vivo demonstration for a locally reduced iNOS expression in patients with RMS and sepsis during the course of the disease. The absence of sinus iNOS indicates the significance of other forms of inflammatory response. Accordingly, we found lymphocytes and neutrophils in maxillary sinus biopsies of patients with RMS and sepsis. Recent investigations suggest that high levels of NO inhibit neutrophilic chemotaxis (40) and proliferative responses in human lymphocytes (41) . Therefore, reduction of the intense expression may favor the inflammatory response. There is evidence from in vitro and experimental in vivo studies that certain cytokines such as interleukin-4, interleukin-6, interleukin-10, interleukin-11,-interleukin-13, and in particular transforming growth factorbeta-1, are able to reduce iNOS expression (42) . Administration of exogenous transforming growth factor-beta-1 markedly reduced iNOS messenger ribonucleic acid in several organs in an experimental model of septic shock (43) .
It might be argued that the reduced maxillary iNOS expression in patients with RMS and sepsis might result as a consequence of the immunomodulatory effects of corticosteroid therapy. First, however, only six out of eleven patients with RMS received hydrocortisone and there was no significant difference in maxillary NO net excretion when compared to RMS patients without this treatment. Second, the dose which we used in patients with RMS and septic shock was low and control patients also received glucocorticosteroids before the measurements. Third, all patients with RMS and sepsis increased their maxillary sinus NO release in the time period following fenestration despite of ongoing corticosteroid therapy. In particular, the single patient who reached a maxillary sinus NO concentration in the range of the controls still received hydrocortisone at a dose of 250 mg/day at the time of the measurement. Based on these arguments a decisive effect of corticosteroids on our results appears to be unlikely.
Our data are in line with results of a study in children with acute sinusitis, whose nasal NO levels were found to be significantly lower than in healthy controls (44) . In addition, Lindberg and coworkers reported reduced NO levels in the nasal cavity of patients with chronic sinusitis (45) .
Up to now, it has remained uncertain whether these findings are a consequence of a reduced maxillary NO production or may be mainly caused by an obstruction of the sinus ostia. The latter interpretation has been preferred (44) and was supported by further investigations in patients with nasal polyposis, in whom the nasally measured NO concentration was inversely correlated with the number of occluded paranasal sinuses (46) . Our data, however, indicate that reduced iNOS expression might also contribute to the reduced NO release as an important factor. This view is supported by the detection of messenger ribonucleic acids for the iNOS supressing cytokines interleukin-4, interleukin-6, and transforming growth factor-beta-1 in maxillary sinus mucosa of patients with chronic sinusitis (47) .
It should, however, be considered that the etiology of RMS in septic patients may be different from an infectious or allergic sinusitis in non ventilated patients. A characteristic feature of sepsis is that it can induce local inflammatory reactions in all tissues by circulating mediators. In this context, it is conceivable that in particular mucous membranes, including paranasal sinus mucosa, may become affected. The limited number of patients with histological and microbiologic evidence of infection and the lacking indication of an allergic genesis in our patients suggest in fact a major role for a sepsis related systemic trigger rather than an endoluminal invasion of bacteria or other pathogens. Therefore, a possible extension of our results to sinusitis in other clinical situations should be the subject of future investigations.
Brett and Evans described decreased exhaled NO concentrations in patients with acute respiratory distress syndrome (48) . On a first glance, this seems to be an analogous situation where the regional synthesis (i.e. production on the alveolar level) of NO is impaired. Based on our findings, it could be argued that the seemingly reduced alveolar NO synthesis might be a consequence of reduced iNOS expression within the lung. Careful analysis, however, reveals that 14 on the basis of the published data, these situations cannot be compared. There is no evidence for a decreased pulmonary iNOS expression in acute respiratory distress syndrome from experimental or human studies. In contrast, various experimental models of acute lung injury revealed an increased pulmonary NO synthesis (42, 49) . This supports the interpretation of Brett and Evans (48) that the low pulmonary NO concentrations in patients with acute respiratory distress syndrome resulted primarily from scavenging reactions with other reactive species.
In conclusion, we found that the high maxillary NO levels in human subjects without airway inflammation result from iNOS expression which is ultrastructurally located in cilia and microvilli of the luminal sinus epithelium. This, most likely, serves to improve ciliary function and nonspecific immune defense. In patients with RMS and sepsis, the maxillary NO production is almost completely suppressed by down-regulation of iNOS messenger ribonucleic acid. This highly impaired production needs several weeks to recover. In patients with RMS and sepsis, a sustained local impairment in local host defense and an increased risk for secondary infections can be anticipated. RMS and sepsis 31 ± 10 ** § 10 ± 2 ** § 12 ± 7 23 ± 2 2 ± 1 ** (n=11) 
Study population
The study was conducted according to the principles of the Helsinki Declaration of 1983 and approved by the local ethics committee. With written informed consent given by themselves or by the next of kin, 22 intubated and mechanically ventilated adult patients (11 male, 11 female, body weight 77±5 kg, age 39±3 years) were included in the study. Eleven of these were mechanically ventilated critically ill patients who fulfilled criteria for radiologic maxillary sinusitis (RMS) (E1): total opacification or presence of an air fluid level within one or both maxillary sinuses in computerized tomography scans. Additionally, pansinusitis was diagnosed independently by two blinded radiologists in all patients with RMS according to the following criteria: mucosal thickening or air fluid levels or opacification in at least three sinuses.
Prior to the assessment of RMS, the patients had been intubated and mechanically ventilated for 17±2 days. None of them had received a nasotracheal tube and in all exept one, nasogastric tubes had been placed. In defined time intervals, patients were turned supine (2-4 hours), prone (6 hours), lateral left (2 hours), lateral right (2 hours). All patients with RMS fulfilled the criteria for sepsis (n=1 sepsis; n=3 severe sepsis; n=7 septic shock according to the American College of Chest Physicians / Society of Critical Care Medicine definition (E2)) and underwent fenestration of the maxillary sinuses to eliminate a possible septic focus. During the investigations 6 patients with septic shock received corticosteroids (Hydrocortison, Aventis Pharma, Bad Soden, Germany) at low doses to achieve cortisol plasma levels of 60-80 µg/100 ml for immunomodulatory therapy (E3). According to the American European Consensus Conference (E4), n = 5 patients fulfilled the criteria for acute respiratory distress syndrome.
Eleven adult patients who underwent osteotomy to correct dysgnathia and were otherwise healthy and without evidence of infection or inflammation on histological examination, described below, served as controls. In these patients direct puncture of the maxillary sinus was performed during surgery under general anesthesia. All control patients received corticosteroids (1 g Solu-Decortin, Merck, Darmstadt, Germany) i. v. preoperatively for anti-edematous therapy.
Surgical access to the maxillary sinuses
Before nasal fenestration a standardized protocol for disinfection of the nasal mucosa using povidone/iodine solution and sterile draping was applied. For fenestration of the maxillary sinus, to the inferior nasal meatus, the inferior nasal concha was dislocated towards medial with a nasal speculum and a perforation was made in the medial maxillary sinus wall with a trocar. This opening was widened with a bone punch to a diameter of about 10 mm, and a silicon drain was inserted to reduce a spontaneous closure of the fenestra. Fluid filled sinuses were cleansed repeatedly with saline solution. The purpose of these procedures was to maintain secretory drainage.
Eleven patients, in whom no clinical, radiological and laboratory findings gave evidence for airway or any other systemic inflammation, were scheduled for maxillary osteotomy to correct dysgnathia. These patients served as the control group. Under general anesthesia, the bony anterior sinus wall was exposed on one side after preparation of a mucoperiost flap in the maxilla. Prior to the actual maxillary osteotomy, the maxillary sinus was punctured with a steel needle (Yale Spinal, Becton Dickson, Spain, inner diameter 2 mm) at the lateral and cranial aspect of the canine root apex. If blood or any secretions were aspirated, this patient was excluded from the study.
Gas sampling
For gas sampling in RMS patients a blunt, curved cannula was carefully advanced directly beneath the silicon drainage into the interior of the sinus maxillaris. The cannula was connected to a glass syringe which was itself linked with an occlusive two liter extremely inert and gas tight tedlar bag (Supelco, Sigma-Aldrich, Deisenhofen, Germany). The sampling equipment is shown in figure E 1. We collected 1000 ml of gas in aliquots of 50 ml with a continuous aspiration rate of 0.1 L/minute. If discharge containing blood or secretion was observed on the first aspiration attempt, we cleansed the sinus with physiologic saline solution and repeated gas sampling 10 minutes later. Patients with RMS were investigated in addition, if feasible, between days 2-3, and days 4-27 of their intensive care unit stay.
In controls maxillary gas was sampled in analogous fashion via the steel needle which had been used for puncturing the maxillary sinus as described above.
Measurement of nitric oxide
Nitric oxide (NO) and nitrogen dioxide (NO 2 ) concentrations in the sampled gas were measured immediately using chemiluminescence analysis, in which NO is converted to NO 2 in the presence of an excess of ozone (E5). We used a CLD 700 AL type chemiluminescence analyzer (ECO-PHYSICS, Duernten, Switzerland). This instrument performs accurate measurements of NO and NO 2 in a range between 1 and 100,000 parts per billion (ppb). Reliability in the lower range was checked with dilutions of a certified test gas containing 200 ppb NO (AGA, Bottrop, Germany).
Net NO excretion rate into the maxillary sinus was calculated with NO concentration differences between sampled gas and ambient air, multiplying this quantity by the sampling flow rate of 0.1 L/minute.
There were two major factors contributing to the variability in the measured values. During the time interval needed to transport the tedlar bag with the gas probe to the analyzer, a part of the NO was converted to NO 2 by reaction with oxygen. The rate of conversion depends on the magnitude of the NO concentration (E5). This effect was the main source of error in controls because of their high NO levels. Due to a short time interval between gas sampling and measurement we were able to keep this deviation below 10%. In contrast, measured values in RMS patients were mainly influenced by the NO already contained in the ambient air which continuously replaced the sampled gas in the maxillary sinuses. The error induced by the ambient NO concentration was minimized by calculating net excretion rates. Results of repeated measurement in 8 RMS patients revealed no significant differences. All values were reproducible within a maximum range of 10%.
Mucosal swabs and biopsies
Swabs for bacterial cultures and open mucosal biopsies of maxillary sinus epithelium for histological and molecularbiological examination were taken from n=6 patients and n=6 controls.
In RMS patients, swabs and biopsies were taken in context with the widening of the fenestra. In controls these procedures were undertaken immediately following actually maxillary osteotomy.
Epithelial biopsies in both groups were cautiously harvested by means of a biopsy forceps.
Immunohistochemistry
Cryostat sections (5 µm) were incubated for 30 min in 0.7% Triton X-100 (Sigma-Aldrich, Taufkirchen, Germany) solved in phosphate-buffered saline (PBS), blocked with 5% skim-milk in PBS, pH 7.4, treated with a primary anti-inducible nitric oxide synthase (iNOS) antibody (E6) diluted 1:200 in PBS containing 5% skim-milk for 2 hours at room temperature, and then kept at 4°C overnight. For signal detection, a secondary horse-radish peroxidase-conjugated swine antirabbit antibody (DAKO, Copenhagen, Denmark), diluted 1:100 in skim-milk PBS was applied for 1 hour at room temperature followed by 5 to 10 minutes incubation with diaminobenzidine.
The light microscopical images were obtained with a digital camera (Spot 32, Diagnostic
Instruments, Munich, Germany) and processed with a MetaVue 4.6r3 software (Universal Imaging Corporation, Downingtown, PA). 
Ultrastructural analyses
For fine structural immunoperoxidase labeling, an established protocol was used (E8). Briefly, 30 µm thick cryostat sections were incubated in 0.5% bovine serum albumine and the primary antiiNOS antibody diluted 1:25 in skim-milk PBS overnight in microtiter plates. On the next day, the sections were treated with the secondary peroxidase-labeled antibody, diluted 1:25, followed by diaminobenzidine / hydrogen peroxide 1%, postfixed with 1% osmium tetroxide, rinsed in maleate buffer, stained en bloc with uranyl acetate, and flat-embedded in Epon 812. Semithin sections (1 µm) were produced and photographed by using a light microscope. Ultrathin sections (60 nm) were then cut and viewed by electron microscopy.
in situ hybridization
An iNOS riboprobe was generated from a 3130-3853 base pair complementary deoxyribonucleic acid. The plasmid was linearized and then in vitro transcribed using digoxigenin-labeled uridine 5'-triphosphate (Roche, Mannheim, Germany). The hybridization on 5 µm cryostat sections was performed as described (E9) overnight at 50°C with about 30 ng of the labeled probe in 40 µl buffer per section. Sections were then incubated for 2 hours with an alkaline phosphatase labeled anti-digoxigenin antibody (DAKO, Copenhagen, Denmark; dilution 1:50). After an incubation time of two hours with a phosphatase substrat mixture containing nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate, the slides were washed and analyzed by high-resolution interference-contrast microscopy.
Histologic analysis
For histological examination formalin-fixed, paraffin-embedded 4 µm sections were cut and stained with hematoxylin-eosin. In 10 high-power fields (x40) the total number of infiltrating inflammatory cells was determined in each ocular location.
Statistical analysis
Differences between groups were explored with the Mann-Whitney-U test. Intra-group comparisons were performed using the Friedman ANOVA followed by post hoc tests according A cannula was inserted into the maxillary sinus and gas was suctioned via a water trap into a glass syringe. During a time period of 24 seconds, 50 ml of gas were manually sampled at a constant flow rate, and than transferred within one second into the tedlar bag which was connected to the syringe via a three-way stopcock. 
